SE333151B - Foerfarande foer framstaellning av nya centralt haemmande verkande aminosyror och salter daerav - Google Patents
Foerfarande foer framstaellning av nya centralt haemmande verkande aminosyror och salter daeravInfo
- Publication number
- SE333151B SE333151B SE8340/64A SE834064A SE333151B SE 333151 B SE333151 B SE 333151B SE 8340/64 A SE8340/64 A SE 8340/64A SE 834064 A SE834064 A SE 834064A SE 333151 B SE333151 B SE 333151B
- Authority
- SE
- Sweden
- Prior art keywords
- aciding
- inhibiting
- salts
- procedure
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH853763A CH446376A (de) | 1963-07-09 | 1963-07-09 | Verfahren zur Herstellung neuer Aminosäuren |
| CH672964 | 1964-05-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE333151B true SE333151B (sv) | 1971-03-08 |
Family
ID=25700075
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8340/64A SE333151B (sv) | 1963-07-09 | 1964-07-08 | Foerfarande foer framstaellning av nya centralt haemmande verkande aminosyror och salter daerav |
| SE08943/67A SE348460B (pt) | 1963-07-09 | 1964-07-08 | |
| SE08945/67A SE348462B (pt) | 1963-07-09 | 1964-07-08 | |
| SE08944/67A SE348461B (pt) | 1963-07-09 | 1964-07-08 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE08943/67A SE348460B (pt) | 1963-07-09 | 1964-07-08 | |
| SE08945/67A SE348462B (pt) | 1963-07-09 | 1964-07-08 | |
| SE08944/67A SE348461B (pt) | 1963-07-09 | 1964-07-08 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3471548A (pt) |
| BE (1) | BE650258A (pt) |
| BR (1) | BR6460727D0 (pt) |
| CH (1) | CH449645A (pt) |
| DE (1) | DE1493536B1 (pt) |
| ES (1) | ES301814A1 (pt) |
| FR (2) | FR3677M (pt) |
| GB (1) | GB1017439A (pt) |
| SE (4) | SE333151B (pt) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3956314A (en) * | 1970-07-24 | 1976-05-11 | U.C.B., Societe Anonyme | Derivatives of 2-pyrrolidinone |
| US3947579A (en) * | 1974-06-03 | 1976-03-30 | Nelson Research & Development Company | Method and composition for potentiating neuroleptic drugs |
| US3978216A (en) * | 1974-06-03 | 1976-08-31 | Nelson Research & Development Company | Method for treating schizophrenia and method and composition for potentiating neuroleptic drugs |
| US4084000A (en) * | 1975-07-16 | 1978-04-11 | Nelson Research And Development Company | Method of treating schizophrenia |
| US4126684A (en) * | 1976-02-11 | 1978-11-21 | Ciba-Geigy Corporation | 4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse |
| NL7706429A (nl) * | 1977-06-10 | 1978-12-12 | Univ Erasmus | Werkwijze voor de bereiding van een geneesmid- del met angst en angstequivalenten opheffende werking en gevormd geneesmiddel met een derge- lijke werking. |
| NL8006135A (nl) * | 1980-11-10 | 1982-06-01 | Univ Erasmus | Geneesmiddel met angst en angstequivalenten opheffende werking en werkwijze voor de bereiding van een dergelijk geneesmiddel. |
| US5006560A (en) * | 1989-12-20 | 1991-04-09 | Schering Corporation | Use of GABA-B selective agonists as anti-tussive agents |
| WO1997022578A1 (en) * | 1995-12-20 | 1997-06-26 | Farmarc Nederland B.V. | A process for the optical resolution of 3-(p-chlorophenyl)-glutaramide |
| PL189872B1 (pl) | 1996-07-24 | 2005-10-31 | Warner Lambert Co | Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu |
| EA200300433A1 (ru) | 2000-11-30 | 2003-10-30 | Пфайзер Продактс Инк. | Комбинация гамк-агонистов и ингибиторов альдегидредуктазы |
| KR20030059290A (ko) | 2000-11-30 | 2003-07-07 | 화이자 프로덕츠 인코포레이티드 | Ｇａｂａ 작용제 및 소르비톨 데하이드로게나제 억제제의혼합물 |
| BRPI0410271A (pt) * | 2003-05-16 | 2006-05-16 | Pfizer Prod Inc | combinações terapêuticas de antipsicóticos atìpicos com moduladores de gaba, anticonvulsivantes ou benzodiazepinas |
| PT1660440E (pt) * | 2003-08-20 | 2012-05-15 | Xenoport Inc | Pró-fármacos de aciloxialquilcarbamato, métodos de síntese e utilização |
| EP2354120A1 (en) | 2003-08-20 | 2011-08-10 | XenoPort, Inc. | Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof |
| PL1691811T3 (pl) | 2003-12-11 | 2014-12-31 | Sunovion Pharmaceuticals Inc | Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji |
| WO2005082372A1 (en) * | 2004-01-29 | 2005-09-09 | Pfizer Products Inc. | COMBINATION OF γ-AMINOBUTYRIC ACID MODULATORS AND 5-HT 1B RECEPTOR ANTAGONISTS |
| WO2007025177A2 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| EP2377530A3 (en) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
| US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
| EP2377531A2 (en) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| US20100197789A1 (en) | 2006-08-11 | 2010-08-05 | National University Corporation Nagoya University | Anti-obesity agent and use thereof |
| MX2009002496A (es) | 2006-09-08 | 2009-07-10 | Braincells Inc | Combinaciones que contienen un derivado de 4-acilaminopiridina. |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| KR20090121388A (ko) * | 2007-03-15 | 2009-11-25 | 썬 파마 어드밴스트 리서치 컴패니 리미티드 | 신규 전구약물 |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| WO2011113904A1 (en) | 2010-03-17 | 2011-09-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration |
| EP3322691A4 (en) | 2015-07-13 | 2019-03-27 | Piramal Enterprises Limited | IMPROVED PROCESS FOR THE PREPARATION OF BACLOFEN AND ITS INTERMEDIATE |
| CN106187794A (zh) * | 2016-07-12 | 2016-12-07 | 安徽省逸欣铭医药科技有限公司 | 一种巴氯芬的绿色工业化生产方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3125583A (en) * | 1964-03-17 | Hjnc oxchaxohxchc o oh |
-
1963
- 1963-07-09 CH CH1468666A patent/CH449645A/de unknown
-
1964
- 1964-06-24 GB GB26174/64A patent/GB1017439A/en not_active Expired
- 1964-06-30 US US379365A patent/US3471548A/en not_active Expired - Lifetime
- 1964-07-03 DE DE19641493536 patent/DE1493536B1/de active Pending
- 1964-07-08 SE SE8340/64A patent/SE333151B/xx unknown
- 1964-07-08 ES ES0301814A patent/ES301814A1/es not_active Expired
- 1964-07-08 SE SE08943/67A patent/SE348460B/xx unknown
- 1964-07-08 BE BE650258A patent/BE650258A/xx unknown
- 1964-07-08 SE SE08945/67A patent/SE348462B/xx unknown
- 1964-07-08 SE SE08944/67A patent/SE348461B/xx unknown
- 1964-07-08 BR BR160727/64A patent/BR6460727D0/pt unknown
- 1964-09-15 FR FR988115A patent/FR3677M/fr active Active
- 1964-09-15 FR FR988116A patent/FR3692M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| SE348460B (pt) | 1972-09-04 |
| BE650258A (pt) | 1965-01-08 |
| FR3677M (fr) | 1965-11-08 |
| ES301814A1 (es) | 1965-01-01 |
| DE1493536B1 (de) | 1971-10-14 |
| BR6460727D0 (pt) | 1973-08-02 |
| SE348462B (pt) | 1972-09-04 |
| SE348461B (pt) | 1972-09-04 |
| CH449645A (de) | 1968-01-15 |
| US3471548A (en) | 1969-10-07 |
| GB1017439A (en) | 1966-01-19 |
| FR3692M (fr) | 1965-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE333151B (sv) | Foerfarande foer framstaellning av nya centralt haemmande verkande aminosyror och salter daerav | |
| SE7612202L (sv) | Nya aminobensoesyraamider och forfarande for framstellning av dessa. | |
| SE417512B (sv) | Forfarande for framstellning av substituerade furankarboxylsyror samt estrar och salter derav | |
| AT278025B (de) | Verfahren zur Herstellung von neuen 3,1-Benzoxazin-Derivaten und ihren Salzen | |
| AT284115B (de) | Verfahren zur Herstellung von neuen 2-Arylhydrazinoimidazolinen-(2) und ihren Salzen | |
| DK119877B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme carboxylsyrer eller farmaceutisk acceptable salte heraf. | |
| AT277234B (de) | Verfahren zur Herstellung von neuen heterocyclischen Amidoximen und ihren Salzen | |
| AT278023B (de) | Verfahren zur Herstellung von neuen Aniliden der Chinuclidin-2- und Chinuclidin-3-carbonsäure und ihren Salzen | |
| AT257591B (de) | Verfahren zur Herstellung von neuen Benzimidazolderivaten und ihren Salzen | |
| AT289828B (de) | Verfahren zur Herstellung von neuen Benzimidazolderivaten und ihren Salzen | |
| FR1448762A (fr) | Esters d'acides cyclododécadiène-carboxyliques | |
| AT277248B (de) | Verfahren zur Herstellung von neuen Isochinolinderivaten und Salzen hievon | |
| AT273108B (de) | Verfahren zur Herstellung von neuen 2-Phenylamino-2-oxazolinen und ihren Salzen | |
| AT273150B (de) | Verfahren zur Herstellung von neuen 3-Dimethylsulfamoyl-phenthiazinderivaten und ihren Salzen | |
| AT273104B (de) | Verfahren zur Herstellung von neuen 2-Phenylamino-2-oxazolinen und ihren Salzen | |
| AT273109B (de) | Verfahren zur Herstellung von neuen 2-Phenylimino-oxazolidinen und ihren Salzen | |
| AT284821B (de) | Verfahren zur Herstellung von neuen N-(tert.-Aminoalkyl)-2-alkinyloxybenzamiden und ihren Salzen | |
| DK119409B (da) | Fremgangsmaade til fremstilling af terapeutisk virksomme n-(gamma-tert.-aminopropyl)-alpha-naftylaminer eller syreadditionssalte deraf | |
| FR1440438A (fr) | Séparation d'amino-acides racémiques | |
| AT284116B (de) | Verfahren zur Herstellung von neuen 2-Arylhydrazino-imidazolinen-(2) und ihren Salzen | |
| AT261595B (de) | Verfahren zur Herstellung von reinen 4-Chlor-2-methylphenoxyalkansäuren und ihren Salzen | |
| AT266823B (de) | Verfahren zur Herstellung von neuen aliphatischen α-(3-Indolyl)-carbonsäuren und ihren Salzen | |
| AT261608B (de) | Verfahren zur Herstellung von neuen Oxadiazol-Derivaten und ihren Salzen | |
| CH476694A (de) | Verfahren zur Herstellung von N-(N-(Hydroxycarbonylphenyl)-glycyl)-aminoacetonitrilen | |
| AT276415B (de) | Verfahren zur Herstellung von neuen 3,1-Benzothiazin-Derivaten und ihren Salzen |